
Odi RND Pharma Private Limited
About Odi RND Pharma Private Limited
Data last updated:
Odi RND Pharma Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the social science research segment of the research and development sector. It was incorporated on 19 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U73200OR2019PTC031157. Its GSTIN is 21AACCO9618D1ZQ (Odisha).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kabita Dash and Binaya Kumar Dash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Braja Sundar Mishra New High Court Colony Arunodaya Nagar, Cuttack, Odisha, India – 753012.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Odi RND Pharma Private Limited's registered office is in Cuttack, Odisha. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Braja Sundar Mishra New High Court Colony Arunodaya Nagar, Cuttack, Odisha, India – 753012
- IndustryResearch & Development, Social Science Research
To see the full contact details of Odi RND Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Odi RND Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Odi RND Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2019-20 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Odi RND Pharma Private Limited, buy the company report.
Board of directors of Odi RND Pharma Private Limited
Odi RND Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kabita Dash | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
| Binaya Kumar Dash | Director | 28 Aug 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Odi RND Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Odi RND Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Odi RND Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AACCO9618D1ZQ | Odisha | Active | 17 Mar 2020 |
To see the full GST registrations and return filing status of Odi RND Pharma Private Limited, buy the company report.
Recent activity
Odi RND Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Braja Sundar Mishra ceased to be Director on 29 Aug 2022.
Frequently asked questions
Odi RND Pharma is an active private limited company based in Cuttack, Odisha, India. The company works in social science research, within the research and development industry. It was incorporated on 19 June 2019 (7+ years old) and is registered under CIN U73200OR2019PTC031157.
Odi RND Pharma has 2 current directors:
- Kabita Dash - Director
- Binaya Kumar Dash - Director
The latest financial statements of Odi RND Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Odi RND Pharma is 21AACCO9618D1ZQ, registered in Odisha.
The CIN (Corporate Identification Number) of Odi RND Pharma is U73200OR2019PTC031157. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Odi RND Pharma was incorporated on 19 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Cuttack.
Braja Sundar Mishra ceased to be Director on 29 Aug 2022. Binaya Kumar Dash was appointed as Director on 28 Aug 2022. Kabita Dash was appointed as Director on 19 Jun 2019.
The registered office of Odi RND Pharma is at CO Braja Sundar Mishra New High Court Colony Arunodaya Nagar, Cuttack, Odisha, India – 753012.
Odi RND Pharma operates in the research and development industry, in the social science research segment.
The compliance status of Odi RND Pharma is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.

